About Green Bay Oncology-Manistique
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
2
Clinical Trials at Green Bay Oncology-Manistique
During the past decade, Green Bay Oncology-Manistique conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2016-02-04
2023-12-30
Active, not recruiting
579
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Green Bay Oncology-Manistique"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Green Bay Oncology-Manistique
According to Clinical.Site data, the most researched conditions in "Green Bay Oncology-Manistique" are
"Fallopian Tube Transitional Cell Carcinoma" (2 trials), "Ovarian Transitional Cell Carcinoma" (2 trials), "Acinar Cell Carcinoma" (1 trials), "Adenoid Cystic Carcinoma" (1 trials) and "Adrenal Cortical Carcinoma" (1 trials). Many other conditions were trialed in "Green Bay Oncology-Manistique" in a lesser frequency.
Clinical Trials Intervention Types at Green Bay Oncology-Manistique
Most popular intervention types in "Green Bay Oncology-Manistique" are "Biological" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (1 trials), "Carboplatin" (1 trials), "Cediranib Maleate" (1 trials), "Gemcitabine" (1 trials) and "Gemcitabine Hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Green Bay Oncology-Manistique
The vast majority of trials in "Green Bay Oncology-Manistique" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Green Bay Oncology-Manistique
Currently, there are NaN active trials in "Green Bay Oncology-Manistique".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Green Bay Oncology-Manistique,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Green Bay Oncology-Manistique, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".